top of page

Pre-Clinical Research​

Computational Bioinformatic Studies ​

  • Patients’ datasets integrating tumor molecular profiling and patient survival data uncover candidate biomarker genes for diagnostic tumor subtyping and personalized treatment. ​

  • Data mining and virtual drug screening to identify targets and candidate drugs

Pre-clinical Testing In Vitro ​

  • Glioblastoma cells grown in cell culture dishes, neurosphere cultures, 3-D Organoids to recapitulate patient’ tumor features, and models to mimic the blood brain barrier, or tumor blood vessel formation (angiogenesis).​

  • Screening and testing new chemotherapy, targeted therapy, FDA-approved drugs, radiation, natural products.​

  • Drug selectivity to target cancer cells and spare normal cells.​

  • Candidate drugs are tested alone and combined to other treatments to evaluate inhibition of proliferation and cell killing

Pre-clinical Testing In Vivo ​

  • In vitro pre-clinical findings are validated for safety and efficacy in mice or rat glioblastoma models before clinical evaluation in humans. ​

  • Glioblastoma patient-derived xenograft (PDX) models represent intratumoral heterogeneity and invasiveness of the original tumor and predict response to treatment.​

  • High cost and technical expertise limit the translation of in vivo findings into clinical trials.

Follow us on Instagram

CONTACT US

For questions, sponsorship requests, and other inquiries, please email jdtfoundation7@gmail.com

Official event sponsor

  • Instagram

© 2024 Jason Di Tullio Foundation

®️ LA GR7NTA is an official registered trademark

bottom of page